Published on
Nov 24, 2022
Novel Mucoadhesive Chitosomes as a Platform for Enhanced Oral Bioavailability of Cinnarizine
Introduction Cinnarizine (CIN) (Figure 1) (1-(diphenylmethyl)-4-(3-phenyl-2-propenyl) piperazine) is a calcium channel blocker and antihistaminic drug, which is used in the treatment of nausea, vomiting, vertigo, motion sickness and Meniere’s disease. It …
Source:
Dove Medical Press
-
Neutral
